why choose us

Clinical Trials Search

Showing 10,340 of 132,963 result(s)
Digital Connections: an EHealth Group Intervention for Young Adult Cancer Survivors

Status: COMPLETED

Condition: Cancer

Interventions: Participants will attend group sessions with a trained facilitator held over videoconference.
Sessions will each last 2 hours and be held once we

Date: 2023-07-11

Thoracic Spine and Shoulder Kinematics and Muscle Activation in Rock Climbers with Shoulder Pain

Status: COMPLETED

Condition: Shoulder Pain

Interventions: arm elevation in the scapular plane, overhead reaching to the target 15° backward to the frontal plane, pull-up with overhead reaching forward and bac

Date: 2023-07-11

Protective Arm Balance Responses

Status: COMPLETED

Condition: Old Age; Debility

Interventions: Participants will be trained in the reach to grasp arm balance response while being exposed to unpredictable balance perturbations

Date: 2023-07-11

Proof-of-concept Study with NVDX3 for Treatment of Distal Radius Fractures.

Status: COMPLETED

Condition: Distal Radius Fractures

Interventions: NVDX3 is implanted during a single surgical intervention.

Date: 2023-07-11

Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care Delivery

Status: COMPLETED

Condition: Vulvar Cancer

Interventions: The intervention consists of a rapid (less than 10-minute) communication intention elicitation exercise (via Freelisting), which is conducted independ

Date: 2023-07-10

Data Collection Protocol for Patients With Von Hippel Lindau Disease

Status: Completed

Condition: Von Hippel Lindau Disease

Interventions:

Date: 2023-07-10

ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions

Status: Completed

Condition: Myelodysplastic Syndromes

Interventions: Specified dose on specified days

Date: 2023-07-10

FT522 With Rituximab in Relapsed;Refractory B-Cell Lymphoma (FT522-101)

Status: Completed

Condition: Relapsed;Refractory B-Cell Lymphoma

Interventions: FT522 drug product is administered as an intravenous infusion on Days 1, 4 and 8 of a treatment cycle.

Date: 2023-07-10

Reminder Messages for Lung Cancer Screening

Status: Completed

Condition: Skin Flaps

Interventions:

Date: 2023-07-10